Help & Support
A calm, source-backed guide to how clinical trial search works today, what makes it hard, and how ClinicalMatchMate is designed to help organize the next step.
Use this page to prepare your information, understand what a trial listing can and cannot tell you, and know what to ask before you contact a study team.
Sources: National Cancer Institute, ClinicalMatchMateCMM-001, CMM-003, CMM-004, CMM-005, CMM-015
Patient-safe boundary
ClinicalMatchMate can help organize and explain trial options, but trial teams determine final eligibility and care decisions should be discussed with a qualified clinician.
Orient
The real-world workflow is not broken because patients are doing something wrong. It is hard because trial information is specific, distributed, and often written for clinical or research teams.
Public registries, NCI resources, hospital pages, sponsor listings, and advocacy resources can all contain useful trial information. Official guidance notes that no single list contains every clinical trial.
Sources: National Cancer InstituteCMM-003
Eligibility criteria are the requirements a person must meet to join a trial. They can depend on diagnosis details, prior treatment, age, medical history, current health status, and condition-specific markers when relevant.
Sources: National Cancer InstituteCMM-002, CMM-005
Protocol summaries can include medical language because they are often written for health care providers. That can make it difficult to tell whether a listing is worth discussing with a clinician or coordinator.
Sources: National Cancer InstituteCMM-004
Visit schedules, travel distance, costs, time away from daily life, and who manages care can all matter before someone decides whether to move forward.
Sources: National Cancer InstituteCMM-009, CMM-010
Standard public workflow
This follows official guidance for people who are searching public listings and then deciding what to ask a doctor or study team.
Start with the condition or diagnosis, stage or subtype when relevant, prior treatments, current health status, location, and preferences.
Friction: Patients may not have all of these details or may need help from their care team.
Sources: National Cancer InstituteCMM-002, CMM-006
People may search ClinicalTrials.gov, NCI tools, hospitals, sponsors, advocacy groups, or listing services.
Friction: Different lists can contain different trials and levels of detail.
Sources: National Cancer InstituteCMM-003, CMM-006
Trial records can include eligibility, location, contact details, trial phase, objectives, lead organization, and trial IDs.
Friction: Medical language and inclusion/exclusion criteria can be hard to interpret without clinical context.
Sources: National Cancer Institute, National Cancer InstituteCMM-004, CMM-005, CMM-008
A person may compare whether the trial objective, eligibility, location, and study length seem realistic enough to ask about.
Friction: A trial can look relevant online but still be impractical or not clinically appropriate.
Sources: National Cancer Institute, National Cancer InstituteCMM-005, CMM-010
The study listing may include a phone number, email, or office contact. NCI suggests asking for the trial coordinator when contacting a trial team.
Friction: Coordinators may ask clinical questions that patients are not sure how to answer without their care team.
Sources: National Cancer Institute, National Cancer InstituteCMM-006, CMM-008
Before moving forward, people should ask about purpose, risks, benefits, costs, privacy, time commitment, alternatives, and who will manage care.
Friction: Final eligibility and enrollment decisions happen with the trial team and clinician discussion, not from a listing alone.
Sources: National Cancer Institute, National Cancer InstituteCMM-001, CMM-005, CMM-009
ClinicalMatchMate layer
ClinicalMatchMate adds structure and explanation around the public workflow. It is designed to simplify preparation and handoff, not decide eligibility.
ClinicalMatchMate is designed to collect the details that commonly shape trial search, while keeping the experience understandable for patients and caregivers.
Sources: National Cancer Institute, ClinicalMatchMateCMM-002, CMM-015
The platform can help organize trials that may be worth reviewing based on the information provided and available listings.
Sources: National Cancer Institute, ClinicalMatchMateCMM-003, CMM-015
Plain-language summaries can help translate trial purpose, criteria, and next-step questions without saying someone definitely qualifies.
Sources: National Cancer Institute, ClinicalMatchMateCMM-004, CMM-005, CMM-015
The page and platform can help users focus on missing details, logistics, contact information, and questions for a doctor or coordinator.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-008, CMM-009, CMM-010, CMM-015
ClinicalMatchMate can help prepare the conversation with a study team or care team, while preserving the role of coordinators and clinicians.
Sources: National Cancer Institute, ClinicalMatchMateCMM-001, CMM-005, CMM-015
Public trial data can change over time, so candidate trials should be reviewed again before outreach or referral.
Sources: Clinical Trials Transformation Initiative, Electronic Code of Federal Regulations, ClinicalMatchMateCMM-014, CMM-015
Compare
Patients and clinical teams need different support. These comparisons keep those paths separate.
A plain-language view of what becomes easier to organize while preserving the patient, caregiver, clinician, and trial-team roles.
Sources: National Cancer Institute, ClinicalMatchMateCMM-003, CMM-015
Without ClinicalMatchMate
Across registries, hospital pages, sponsor sites, advocacy groups, or conversations with a care team.
With ClinicalMatchMate
In one guided flow that helps organize information and surface candidate trials to review.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-002, CMM-007, CMM-015
Without ClinicalMatchMate
Diagnosis or condition details, prior treatments, age, health status, location, and preferences may need to be gathered manually.
With ClinicalMatchMate
The same details are requested in a more structured way so gaps are easier to notice before outreach.
Sources: National Cancer Institute, ClinicalMatchMateCMM-004, CMM-005, CMM-015
Without ClinicalMatchMate
Protocol summaries and eligibility criteria may use provider-oriented language.
With ClinicalMatchMate
Plain-language explanations can help users understand why a trial may look relevant and what still needs review.
Sources: National Cancer Institute, National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-006, CMM-008, CMM-009, CMM-015
Without ClinicalMatchMate
The patient, caregiver, or clinician uses the listing contact information and asks the study team about fit.
With ClinicalMatchMate
Contact details and questions can be organized for a more prepared handoff or conversation.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-001, CMM-005, CMM-009, CMM-010, CMM-015
Without ClinicalMatchMate
Whether the possible benefits, risks, time, travel, costs, and alternatives feel worth discussing further.
With ClinicalMatchMate
The same decision remains with the patient, caregiver, care team, and trial team. ClinicalMatchMate does not make the decision for them.
An operational view of structured search, referral preparation, and coordinator handoff without overstating automation.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-003, CMM-007, CMM-015
Without ClinicalMatchMate
Clinicians or coordinators may search registries, local trial lists, sponsor pages, or institution-specific resources.
With ClinicalMatchMate
ClinicalMatchMate is designed to organize patient-provided details against candidate trials for review.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-002, CMM-007, CMM-015
Without ClinicalMatchMate
Key details may be scattered across notes, labs, pathology, patient recall, and referral messages.
With ClinicalMatchMate
Structured intake can make missing or uncertain search details easier to identify before a handoff.
Sources: National Cancer Institute, PubMed, ClinicalMatchMateCMM-004, CMM-005, CMM-012, CMM-015
Without ClinicalMatchMate
Staff may need to interpret protocol summaries and eligibility criteria under time constraints.
With ClinicalMatchMate
Plain-language fit explanations can support review, while final eligibility remains with the trial team.
Sources: National Cancer Institute, PMC, ClinicalMatchMateCMM-008, CMM-013, CMM-015
Without ClinicalMatchMate
Handoffs can depend on emails, calls, local knowledge, and what contact details are available in the listing.
With ClinicalMatchMate
Candidate-trial summaries and next-step questions can help prepare a cleaner referral or coordinator conversation.
Sources: U.S. Food and Drug Administration, PubMed, PMC, ClinicalMatchMateCMM-011, CMM-012, CMM-013, CMM-015
Without ClinicalMatchMate
Teams may have limited visibility into where patients get stuck: missing data, eligibility uncertainty, logistics, or contact friction.
With ClinicalMatchMate
A structured workflow can help surface those bottlenecks without claiming to solve enrollment or outcomes on its own.
Prepare
You do not need to have every answer before you start. The goal is to gather enough context to ask better questions.
Bring the specific condition name, stage or subtype if relevant, and any biomarker or genetic information your care team has already discussed with you.
Sources: National Cancer InstituteCMM-002
Many trials ask whether you have received certain treatments before. A treatment list can help a coordinator or clinician check fit.
Sources: National Cancer InstituteCMM-002
Eligibility can depend on general health, medical history, and recent test information. Ask your care team what is relevant for your situation.
Sources: National Cancer InstituteCMM-002, CMM-005
Think about travel distance, visit frequency, time commitment, costs, and support needs before contacting a study team.
Sources: National Cancer InstituteCMM-009, CMM-010
Before contacting a trial
Use these themes with your doctor, a nurse, social worker, or the study coordinator. The right questions depend on the trial and your situation.
Ask what the study is trying to learn and how the trial compares with standard options.
Sources: National Cancer InstituteCMM-009
Ask what side effects or risks are known, what benefits are possible, and how uncertainty will be handled.
Sources: National Cancer InstituteCMM-009
Ask which costs are covered by the trial, which may go through insurance, and who can answer payment questions.
Sources: National Cancer InstituteCMM-009, CMM-010
Ask about visits, tests, travel, hospital stays, follow-up, and how long you have to decide.
Sources: National Cancer InstituteCMM-009, CMM-010
Ask who to contact during and after the trial, who is in charge of care, and how health information is kept private.
Sources: National Cancer InstituteCMM-009
Ask how the trial compares with other choices and what options remain if you decide not to join or later leave.
Sources: National Cancer Institute, National Cancer InstituteCMM-001, CMM-009
Operational support
ClinicalMatchMate should fit into real clinical workflows, not pretend those workflows are simple. The goal is to support structured search, clearer patient-facing explanations, and cleaner next-step handoffs without replacing review by clinicians or study teams.
Search criteria can include condition, age, location, treatment, phase, identifiers, investigators, and lead organization. A structured workflow can help keep those variables visible.
Sources: National Cancer Institute, ClinicalMatchMateCMM-007, CMM-015
Because summaries and eligibility language can be difficult for patients, ClinicalMatchMate is designed to help explain candidate-trial fit in patient-safe language.
Sources: National Cancer Institute, ClinicalMatchMateCMM-004, CMM-005, CMM-015
Operational research describes barriers such as time constraints, limited trial awareness, eligibility complexity, and logistical support. The product can help organize what to review next, but it should not claim to solve those barriers by itself.
Sources: PubMed, PMC, ClinicalMatchMateCMM-012, CMM-013, CMM-015
Institutional value should be framed as workflow support: surfacing candidate trials, preparing referral context, and identifying bottlenecks. Do not assume EHR integration or automated referral unless it is implemented.
Sources: U.S. Food and Drug Administration, ClinicalMatchMateCMM-011, CMM-015
Trust, safety, and limits
This page is intentionally careful. A clinical trial search tool should make the process easier to understand without creating false certainty.
This page and ClinicalMatchMate can help organize information, but medical decisions should be discussed with a qualified care team.
Sources: National Cancer Institute, ClinicalMatchMateCMM-001, CMM-015
A search result or candidate trial is not a guarantee. Final eligibility is determined through the study team's screening process.
Sources: National Cancer Institute, ClinicalMatchMateCMM-005, CMM-015
Public trial records and recruitment status can change over time. Re-check trial details before contacting or referring.
Sources: Clinical Trials Transformation Initiative, Electronic Code of Federal RegulationsCMM-014
Before entering health information, review ClinicalMatchMate privacy and trust materials so you understand how the product describes data use.
Sources: ClinicalMatchMateCMM-015
For current product privacy language, review Privacy & Trust.
FAQ
Short answers based only on approved claims in the source manifest.
No. ClinicalMatchMate can help surface candidate trials and explain why they may look relevant, but the study team determines final eligibility through screening.
Sources: National Cancer Institute, ClinicalMatchMateCMM-005, CMM-015
Yes. Official guidance recommends discussing trial options and search results with your doctor or another member of your care team.
Sources: National Cancer InstituteCMM-001
Trial fit often depends on details such as diagnosis, stage or subtype when relevant, prior treatments, age, medical history, and current health status.
Sources: National Cancer InstituteCMM-002, CMM-005
A listing may not show every practical or clinical issue. Eligibility, timing, site capacity, travel, costs, and care-team judgment can all affect whether next steps make sense.
Sources: National Cancer Institute, National Cancer Institute, Clinical Trials Transformation Initiative, Electronic Code of Federal RegulationsCMM-005, CMM-009, CMM-010, CMM-014
Yes. Caregivers can use the page to organize questions and prepare for conversations, while decisions should still involve the patient when possible and the care team.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-001, CMM-009, CMM-015
The product is designed to support structured search and handoff preparation. It should be used as workflow support, not as an automatic eligibility or enrollment decision.
Sources: National Cancer Institute, National Cancer Institute, ClinicalMatchMateCMM-005, CMM-007, CMM-015
Next step
Start with the details you know. ClinicalMatchMate can help turn trial listings into a clearer list of candidate options and next-step questions.
Sources and review metadata
Public trial listings, recruitment status, and guidance evolve. Re-check trial details before contacting or referring, and discuss options with a qualified care team.
Source library
1 of 9
15 claims are mapped to source IDs in the content layer. Hero copy uses only high-confidence official or internal product-boundary claims. Medium-confidence peer-reviewed claims are scoped to the clinician and institution section.
Finding a Trial
Help & Support
How It Works
Help & Support
FAQ
Help & Support
Privacy & Trust
Help & Support
